PL363157A1 - Hormonalna terapia zastępcza - Google Patents

Hormonalna terapia zastępcza

Info

Publication number: PL363157A1
Authority: PL; Poland
Prior art keywords: combination; replacement therapy; hormone replacement; medroxyprogesterone acetate; conjugated estrogens
Prior art date: 2000-03-20

Application number

PL01363157A

Other languages

English (en)

Other versions

PL201762B1 (pl

Inventor

James H. Pickar

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-20

Filing date

2001-03-16

Publication date

2004-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL363157(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-16 Application filed by Wyeth filed Critical Wyeth

2004-11-15 Publication of PL363157A1 publication Critical patent/PL363157A1/pl

2009-05-29 Publication of PL201762B1 publication Critical patent/PL201762B1/pl

Links

229940035811 conjugated estrogen Drugs 0.000 title 1
238000002657 hormone replacement therapy Methods 0.000 title 1
229960002985 medroxyprogesterone acetate Drugs 0.000 title 1
PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)

PL363157A 2000-03-20 2001-03-16 Zastosowanie sprzężonych estrogenów i octanu medroksyprogesteronu do wytwarzania pakietów farmaceutycznych oraz kompozycja farmaceutyczna, jednostka dawkowania i pakiet zawierające sprzężone estrogeny i octan medroksyprogesteronu PL201762B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19063000P	2000-03-20	2000-03-20
US26860701P	2001-02-14	2001-02-14

Publications (2)

Publication Number	Publication Date
PL363157A1 true PL363157A1 (pl)	2004-11-15
PL201762B1 PL201762B1 (pl)	2009-05-29

Family

ID=26886279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL363157A PL201762B1 (pl)	2000-03-20	2001-03-16	Zastosowanie sprzężonych estrogenów i octanu medroksyprogesteronu do wytwarzania pakietów farmaceutycznych oraz kompozycja farmaceutyczna, jednostka dawkowania i pakiet zawierające sprzężone estrogeny i octan medroksyprogesteronu

Country Status (30)

Country	Link
US (2)	US20010034340A1 (pl)
EP (1)	EP1265616B1 (pl)
JP (1)	JP2003527416A (pl)
KR (1)	KR100805648B1 (pl)
CN (1)	CN1239160C (pl)
AR (1)	AR031563A1 (pl)
AT (1)	ATE326227T1 (pl)
AU (2)	AU2001250034B2 (pl)
BG (1)	BG66075B1 (pl)
BR (1)	BR0109334A (pl)
CA (1)	CA2402983A1 (pl)
CY (1)	CY1105632T1 (pl)
CZ (1)	CZ20023162A3 (pl)
DE (1)	DE60119703T2 (pl)
DK (1)	DK1265616T3 (pl)
EA (1)	EA005592B1 (pl)
EE (1)	EE05129B1 (pl)
ES (1)	ES2261393T3 (pl)
HK (1)	HK1049449B (pl)
HR (1)	HRP20020837B1 (pl)
HU (1)	HUP0302093A3 (pl)
IL (1)	IL151512A0 (pl)
MX (1)	MXPA02009116A (pl)
NO (1)	NO326886B1 (pl)
NZ (1)	NZ521171A (pl)
PL (1)	PL201762B1 (pl)
PT (1)	PT1265616E (pl)
SK (1)	SK286169B6 (pl)
TW (1)	TWI271194B (pl)
WO (1)	WO2001070208A2 (pl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6245819B1 (en) *	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
MXPA03008367A (es) *	2001-03-16	2004-11-12	Wyeth Corp	Terapia de reemplazamiento de hormonas.
EP1857110A3 (en) *	2001-03-16	2008-08-06	Wyeth	Hormone replacement therapy
WO2008150547A1 (en)	2007-06-04	2008-12-11	The Regents Of The University Of California	Pregnancy hormone combination for treatment of autoimmune diseases
US20130203722A1 (en)	2006-09-26	2013-08-08	Rhonda R. Voskuhl	Estriol therapy for autoimmune and neurodegenerative disease and disorders
TWI252111B (en) *	2001-12-14	2006-04-01	Solvay Pharm Gmbh	Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
TW200306196A (en) *	2002-04-03	2003-11-16	Wyeth Corp	Hormone replacement therapy
TW200306846A (en) *	2002-04-03	2003-12-01	Wyeth Corp	Hormone replacement therapy
EP1494679A4 (en) *	2002-04-03	2009-10-28	Barr Lab Inc	STEP-BY-STEP ESTROGENTHERAPY
TW200306851A (en) *	2002-04-29	2003-12-01	Wyeth Corp	Hormone replacement therapy
TW200400040A (en) *	2002-05-17	2004-01-01	Wyeth Corp	Hormone replacement therapy
MXPA04012220A (es) *	2002-06-06	2005-04-08	Hormos Medical Corp	Metodo para la inhibicion de la atrofia o para el tratamiento o la prevencion de los sintomas relacionados con la atrofia en mujeres.
RU2005101638A (ru) *	2002-06-25	2006-01-20	Уайт (Us)	Использование циклокарбаматных производных для лечения гормонзависимых состояний
RU2005101635A (ru) *	2002-06-25	2005-08-10	Уайт (Us)	Применение производных тиооксиндола в терапии гормонозависимых состояний
US8349819B2 (en)	2002-10-09	2013-01-08	Dr. Reddy's Laboratories New York, Inc.	Steroid extraction process from urine sources
MXPA05010871A (es) *	2003-04-11	2005-11-25	Barr Lab Inc	Metodos para administrar estrogenos y progestinas.
US20060040904A1 (en) *	2004-08-17	2006-02-23	Ahmed Salah U	Vaginal cream compositions, kits thereof and methods of using thereof
WO2007076144A2 (en)	2005-12-27	2007-07-05	Duramed Pharmaceuticals, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
MX2008012880A (es) *	2006-04-05	2008-10-13	Wyeth Corp	Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local.
TW200831139A (en) *	2006-11-29	2008-08-01	Wyeth Corp	Estrogen/SERM and estrogen/progestin bi-layer tablets
PL2121553T3 (pl) *	2007-02-14	2012-11-30	Hormos Medical Ltd	Sposób wytwarzania cennych terapeutycznie pochodnych trifenylobutenu
WO2008099060A2 (en) *	2007-02-14	2008-08-21	Hormos Medical Ltd	Methods for the preparation of fispemifene from ospemifene
KR100989093B1 (ko)	2008-01-18	2010-10-25	한화제약주식회사	생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
US9734496B2 (en)	2009-05-29	2017-08-15	Paypal, Inc.	Trusted remote attestation agent (TRAA)
ES2773079T3 (es) *	2010-02-08	2020-07-09	Shenzhen Evergreen Therapeutics Co Ltd	Métodos para el uso de progestágeno como sensibilizador de glucocorticoides
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9321712B2 (en)	2012-10-19	2016-04-26	Fermion Oy	Process for the preparation of ospemifene
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US11224603B2 (en) *	2013-12-13	2022-01-18	Requis Pharmaceuticals, Inc.	Antihistamines in combination with a range of substances for improved health
US10799512B2 (en)	2014-04-28	2020-10-13	The Regents Of The University Of California	Estrogen combination for treatment of multiple sclerosis
WO2015168002A1 (en)	2014-04-28	2015-11-05	The Regents Of The University Of California	Pharmaceutical packaging for estriol therapy
EP3145489A1 (en)	2014-05-22	2017-03-29	TherapeuticsMD, Inc.	Natural combination hormone replacement formulations and therapies
EP3188735A4 (en)	2014-09-02	2018-01-24	The Regents of the University of California	Estrogen therapy for brain gray matter atrophy and associated disability
ES2957543T3 (es) *	2014-09-29	2024-01-22	Univ California	Composiciones y métodos para mantener la función cognitiva
WO2016160832A1 (en)	2015-03-30	2016-10-06	The Regents Of The University Of California	Methods of monitoring estriol therapy
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
WO2017173044A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd Inc.	Steroid hormone compositions in medium chain oils
WO2017173071A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
WO2020081726A1 (en) *	2018-10-17	2020-04-23	Stadler Sarah Sheehan	Methods of treating menopausal symptoms using low dose progesterone
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU582540B2 (en) *	1983-08-05	1989-04-06	Pre Jay Holdings Ltd.	A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE3888269T2 (de) *	1987-09-24	1994-07-07	Jencap Research Ltd	Hormon-Zusammensetzung und -Anwendung.
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings
US5759577A (en) *	1995-01-17	1998-06-02	American Home Products Corporation	Controlled release of steroids from sugar coatings

2001
- 2001-03-15 US US09/808,878 patent/US20010034340A1/en not_active Abandoned
- 2001-03-16 EP EP01923331A patent/EP1265616B1/en not_active Expired - Lifetime
- 2001-03-16 AU AU2001250034A patent/AU2001250034B2/en not_active Ceased
- 2001-03-16 HK HK03101651.5A patent/HK1049449B/en not_active IP Right Cessation
- 2001-03-16 SK SK1348-2002A patent/SK286169B6/sk not_active IP Right Cessation
- 2001-03-16 ES ES01923331T patent/ES2261393T3/es not_active Expired - Lifetime
- 2001-03-16 BR BR0109334-7A patent/BR0109334A/pt not_active Application Discontinuation
- 2001-03-16 HR HR20020837A patent/HRP20020837B1/xx not_active IP Right Cessation
- 2001-03-16 DK DK01923331T patent/DK1265616T3/da active
- 2001-03-16 CZ CZ20023162A patent/CZ20023162A3/cs unknown
- 2001-03-16 PT PT01923331T patent/PT1265616E/pt unknown
- 2001-03-16 EA EA200201000A patent/EA005592B1/ru not_active IP Right Cessation
- 2001-03-16 EE EEP200200535A patent/EE05129B1/xx not_active IP Right Cessation
- 2001-03-16 WO PCT/US2001/040302 patent/WO2001070208A2/en not_active Ceased
- 2001-03-16 AT AT01923331T patent/ATE326227T1/de active
- 2001-03-16 HU HU0302093A patent/HUP0302093A3/hu unknown
- 2001-03-16 CN CNB018068235A patent/CN1239160C/zh not_active Expired - Fee Related
- 2001-03-16 IL IL15151201A patent/IL151512A0/xx not_active IP Right Cessation
- 2001-03-16 JP JP2001568406A patent/JP2003527416A/ja active Pending
- 2001-03-16 KR KR1020027012420A patent/KR100805648B1/ko not_active Expired - Fee Related
- 2001-03-16 DE DE60119703T patent/DE60119703T2/de not_active Expired - Lifetime
- 2001-03-16 MX MXPA02009116A patent/MXPA02009116A/es active IP Right Grant
- 2001-03-16 PL PL363157A patent/PL201762B1/pl not_active IP Right Cessation
- 2001-03-16 CA CA002402983A patent/CA2402983A1/en not_active Abandoned
- 2001-03-16 AU AU5003401A patent/AU5003401A/xx active Pending
- 2001-03-16 NZ NZ521171A patent/NZ521171A/en not_active IP Right Cessation
- 2001-03-19 AR ARP010101273A patent/AR031563A1/es unknown
- 2001-03-19 TW TW090106349A patent/TWI271194B/zh not_active IP Right Cessation
2002
- 2002-09-12 BG BG107095A patent/BG66075B1/xx unknown
- 2002-09-19 NO NO20024478A patent/NO326886B1/no not_active IP Right Cessation
2006
- 2006-07-03 CY CY20061100910T patent/CY1105632T1/el unknown
2007
- 2007-11-06 US US11/979,633 patent/US20090005351A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO326886B1 (no)	2009-03-16
WO2001070208A2 (en)	2001-09-27
US20090005351A1 (en)	2009-01-01
SK13482002A3 (sk)	2003-02-04
DE60119703T2 (de)	2006-10-19
BR0109334A (pt)	2002-12-24
JP2003527416A (ja)	2003-09-16
HRP20020837A2 (en)	2004-02-29
EA005592B1 (ru)	2005-04-28
EP1265616A2 (en)	2002-12-18
EP1265616B1 (en)	2006-05-17
EA200201000A1 (ru)	2003-02-27
TWI271194B (en)	2007-01-21
ATE326227T1 (de)	2006-06-15
AR031563A1 (es)	2003-09-24
BG66075B1 (en)	2011-02-28
NO20024478L (no)	2002-09-19
NO20024478D0 (no)	2002-09-19
HK1049449A1 (en)	2003-05-16
NZ521171A (en)	2004-09-24
SK286169B6 (sk)	2008-04-07
CN1418102A (zh)	2003-05-14
CA2402983A1 (en)	2001-09-27
DE60119703D1 (de)	2006-06-22
PL201762B1 (pl)	2009-05-29
WO2001070208A3 (en)	2002-04-25
HK1049449B (en)	2006-07-28
DK1265616T3 (da)	2006-06-12
BG107095A (bg)	2003-05-30
EE200200535A (et)	2004-04-15
EE05129B1 (et)	2009-02-16
HUP0302093A2 (hu)	2003-10-28
KR100805648B1 (ko)	2008-02-26
CN1239160C (zh)	2006-02-01
HUP0302093A3 (en)	2010-03-29
CZ20023162A3 (cs)	2003-03-12
AU5003401A (en)	2001-10-03
ES2261393T3 (es)	2006-11-16
PT1265616E (pt)	2006-08-31
AU2001250034B2 (en)	2005-03-24
IL151512A0 (en)	2003-04-10
CY1105632T1 (el)	2010-12-22
KR20020084230A (ko)	2002-11-04
US20010034340A1 (en)	2001-10-25
MXPA02009116A (es)	2003-03-12
HRP20020837B1 (hr)	2007-08-31

Legal Events

Date	Code	Title	Description
2013-05-31	LAPS	Decisions on the lapse of the protection rights	Effective date: 20120316

Publication	Publication Date	Title
IL151512A0 (en)	2003-04-10	Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
HUP0204291A3 (en)	2003-05-28	Use of composition containing estrogen and drospirenone for hormone replacement therapy
AU3947902A (en)	2002-06-03	Therapeutic agents and methods of use thereof for the modulation of angiogenesis
AU2001273074A1 (en)	2002-01-21	Combinations of ssri and estrogenic agents
HUP0400646A3 (en)	2012-08-28	Steroid hormone-compositions and processes for their preparation
AU2001271785A1 (en)	2002-01-21	Combinations of statins, estrogenic agents and optionally estrogens
PL368730A1 (pl)	2005-04-04	Preformulacja do tabletkowania naturalnych mieszanin sprzężonych estrogenów
HU229606B1 (en)	2014-02-28	Novel combination of loteprednol and antihistamines
AU4134101A (en)	2001-05-30	Hormone receptor functional entities and methods of their use
HUP0103072A3 (en)	2003-07-28	Use of growth hormone secretagogues
IL147253A0 (en)	2002-08-14	Growth hormone formulations
IL149715A0 (en)	2002-11-10	MICROBIAL 9α-HYDROXYLATION OF STEROIDS
HRP20020893A2 (en)	2004-02-29	Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
PL332610A1 (en)	1999-09-27	Hormonal preparation consisting of an oestrogen compound and of a progesterone compound
IL151589A0 (en)	2003-04-10	New combination of a betablocker and a cholestrol-lowering agent
AP2002002475A0 (en)	2002-06-30	Hormonal composition based on a progesterone and an oestrogen and use thereof
AU2001255013A1 (en)	2001-12-03	Combination of growth hormone secretagogues and antidepressants
AU2002217841A1 (en)	2002-05-15	Neuroactive steroid derivatives and methods of use
SI1265616T1 (sl)	2006-08-31	Hormonsko nadomestno zdravljenje z uporabo kombinacije konjugiranih estrogenov in medroksiprogesteron-acetata
IL151523A0 (en)	2003-04-10	Use of avocado-soybean unsaponifiable preparations
PL353487A1 (pl)	2003-11-17	Nowa kombinacja loteprednolu i agonistów beta2 adrenoreceptora
NO20006381D0 (no)	2000-12-14	Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
AU4825200A (en)	2000-11-21	Oral steroidal hormone compositions and methods of use
AU2002304816A1 (en)	2002-12-16	Modulation of steroid hormone uptake
IL156655A0 (en)	2004-01-04	Hormone replacement therapy method and its administration form